| |
| |
|
| Insider
Information: |
Metzger Michael A |
| Relationship: |
|
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
164,909 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,124,106 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
164,909 |
|
|
| Total
Value |
$3,124,106 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Response Genetics Inc |
RGDX |
Director |
2012-02-02 |
1,000 |
2012-02-02 |
0 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
Director |
2022-11-08 |
0 |
2018-01-20 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
163,909 |
2019-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-07-05 |
4 |
OE |
$0.84 |
$76,961 |
D/D |
91,500 |
111,621 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-11-08 |
4 |
OE |
$0.84 |
$86,971 |
D/D |
91,500 |
91,500 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-11-08 |
4 |
AS |
$5.53 |
$511,019 |
D/D |
(91,500) |
0 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
President and COO |
• • – |
2020-11-04 |
4 |
AS |
$20.31 |
$2,031,410 |
D/D |
(100,000) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
President and COO |
• • – |
2020-11-04 |
4 |
OE |
$7.20 |
$720,000 |
D/D |
100,000 |
117,659 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
146,250 |
163,909 |
0 |
- |
|
56 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
